RECURSION PHARMACEUTICALS RXRX 深 沪
等待开盘 08-23 09:30:00 美东时间
4.9651
+0.185
+3.87%
华盛通- 最 高5.17
- 今 开4.78
- 成交量 1787.17万股
- 最 低 4.78
- 昨 收 4.78
- 总市值 21.55亿
- 52周最高 12.36
- 市盈率 静 --
- 换手率 4.12%
- 52周最低 3.79
- 委 比 20.50%
- 总股本 4.34亿
- 历史最高 42.81
- 量 比 0.99
- 振 幅 8.16%
- 历史最低 3.79
- 每 手 1
- 风险率 1.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股夜盘 | SoundHound AI涨4.74%，RECURSION PHARMACEUTICALS涨3.14%
SoundHound AI涨4.74%；RECURSION PHARMACEUTICALS涨3.14%；NuScale Power涨2.99%
08-21 14:02
美股夜盘 | 科尔黛伦矿业涨3.29%，Palantir跌2.35%，加密货币概念股夜盘多数下跌
科尔黛伦矿业涨3.29%，Palantir跌2.35%，加密货币概念股夜盘多数下跌，Bullish跌超3%， Robinhood跌1%，今日夜盘涨跌幅TOP5>>
08-20 08:12
Trump Threatens Pharma With Potential 250% Tariffs In 18 Months: 'We Want Pharmaceuticals Made In Our Country'
President Donald Trump has indicated the possibility of imposing tariffs on imported pharmaceuticals that could rise up to 250%, indicating the highest rate he has proposed so far.
08-06 15:45
Recursion Pharmaceuticals Reports Wider-Than-Expected Q2 Loss, Beats Revenue Estimates
Recursion reported second-quarter revenue of $19.22 million, beating analyst estimates of $16.23 million, according to Benzinga Pro. The company reported a second-quarter loss of 41 cents per share, missing estimates for a loss of 34 cents per share.
08-06 00:08
Earnings Scheduled For August 5, 2025
Companies Reporting Before The Bell • Silicon Laboratories (NASDAQ:SLAB) is exp...
08-05 16:32
Recursion Pharmaceuticals Earnings Preview
Recursion Pharmaceuticals (NASDAQ:RXRX) is gearing up to announce its quarterly...
08-05 01:05
今年最大的科技IPO来了！设计软件巨头Figma上市在即，AI软件股能否借势腾飞？
投资者疯抢！Figma IPO认购火爆，将于7月31日（周四）正式登陆纽交所。作为硅谷炙手可热的设计软件独角兽，Figma成色几何？>>
07-30 17:56
Recursion to Report Second Quarter 2025 Business Updates and Financial Results on August 5th
Recursion announced it will host a quarterly earnings call on August 5, 2025, at 8:00 am ET, to discuss its second-quarter 2025 financial results and business updates. The event will stream live on X (Twitter), LinkedIn, and YouTube, with a Q&A session via a Google Form. Recursion, a clinical-stage TechBio company, uses its Recursion OS platform to decode biology and advance medicine. Investors can find more information on the company’s website o...
07-29 12:00
